Literature DB >> 15276841

Crystal structure of EMS16 in complex with the integrin alpha2-I domain.

Katsunori Horii1, Daiju Okuda, Takashi Morita, Hiroshi Mizuno.   

Abstract

Snake venoms contain a number of heterodimeric C-type lectin-like proteins (CLPs) that interact specifically with components of the haemostatic system. EMS16 from the venom of Echis multisquamatus binds to the collagen receptor, integrin alpha2beta1, also known as glycoprotein (GP) Ia/IIa, and specifically inhibits collagen binding. Here we report the crystal structure of EMS16 in complex with recombinant integrin alpha2-I domain that plays a central role in collagen binding. The structure of the complex at 1.9 Angstrom resolution reveals that the collagen-binding site of the alpha2-I domain is covered completely by the bound EMS16. This blockage by EMS16 appears to spatially inhibit collagen binding to the alpha2-I domain. The bound alpha2-I domain adopts a closed conformation, which is seen in the absence of ligand, suggesting that EMS16 stabilizes a closed conformation corresponding to the less active structure of the alpha2-I domain. EMS16 does not directly bind to the manganese ion and residues of the metal ion-dependent adhesion site (MIDAS) of the alpha2-I domain, suggesting that EMS16 may have the potential to bind specifically to the alpha2-I domain in a metal ion-independent fashion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276841     DOI: 10.1016/j.jmb.2004.06.036

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Deconstructing honeybee vitellogenin: novel 40 kDa fragment assigned to its N terminus.

Authors:  Heli Havukainen; Øyvind Halskau; Lars Skjaerven; Bente Smedal; Gro V Amdam
Journal:  J Exp Biol       Date:  2011-02-15       Impact factor: 3.312

2.  Modulation of TMEM16A channel activity by the von Willebrand factor type A (VWA) domain of the calcium-activated chloride channel regulator 1 (CLCA1).

Authors:  Monica Sala-Rabanal; Zeynep Yurtsever; Kayla N Berry; Colin G Nichols; Tom J Brett
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

3.  Determinants of the specificity of rotavirus interactions with the alpha2beta1 integrin.

Authors:  Fiona E Fleming; Kate L Graham; Yoshikazu Takada; Barbara S Coulson
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

4.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

Review 5.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

6.  Rhinocetin, a venom-derived integrin-specific antagonist inhibits collagen-induced platelet and endothelial cell functions.

Authors:  Sakthivel Vaiyapuri; E Gail Hutchinson; Marfoua S Ali; Abeer Dannoura; Ronald G Stanley; Robert A Harrison; Andrew B Bicknell; Jonathan M Gibbins
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

Review 7.  Pharmacological aspects of Vipera xantina palestinae venom.

Authors:  Tatjana Momic; Franziska T Arlinghaus; Hadar Arien-Zakay; Jeoshua Katzhendler; Johannes A Eble; Cezary Marcinkiewicz; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2011-11-14       Impact factor: 4.546

8.  Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively.

Authors:  Johannes A Eble; Matthew McDougall; George L Orriss; Stephan Niland; Benjamin Johanningmeier; Gottfried Pohlentz; Markus Meier; Simone Karrasch; Maria Inacia Estevão-Costa; Augusto Martins Lima; Jörg Stetefeld
Journal:  PLoS Biol       Date:  2017-07-13       Impact factor: 8.029

Review 9.  Beyond the Matrix: The Many Non-ECM Ligands for Integrins.

Authors:  Bryce LaFoya; Jordan A Munroe; Alison Miyamoto; Michael A Detweiler; Jacob J Crow; Tana Gazdik; Allan R Albig
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.